دورية أكاديمية
أعرض في EDS

Mechanisms of action of anti-inflammatory proteins and peptides with anti-TNF-alpha activity and their effects on the intestinal barrier: A systematic review.

التفاصيل البيبلوغرافية
العنوان: Mechanisms of action of anti-inflammatory proteins and peptides with anti-TNF-alpha activity and their effects on the intestinal barrier: A systematic review.
المؤلفون: Lima MSR; Biochemistry and Molecular Biology Postgraduate Program, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, Brazil., de Lima VCO; Biochemistry and Molecular Biology Postgraduate Program, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, Brazil., Piuvezam G; Public Health Postgraduate Program, Center for Health Sciences, Federal University of Rio Grande do Norte, Natal, RN, Brazil.; Department of Public Health, Federal University of Rio Grande do Norte, Natal, RN, Brazil., de Azevedo KPM; Public Health Postgraduate Program, Center for Health Sciences, Federal University of Rio Grande do Norte, Natal, RN, Brazil., Maciel BLL; Nutrition Postgraduate Program, Center for Health Sciences, Federal University of Rio Grande do Norte, Natal, RN, Brazil.; Department of Nutrition, Federal University of Rio Grande do Norte, Natal, RN, Brazil., Morais AHA; Biochemistry and Molecular Biology Postgraduate Program, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, Brazil.; Nutrition Postgraduate Program, Center for Health Sciences, Federal University of Rio Grande do Norte, Natal, RN, Brazil.; Department of Nutrition, Federal University of Rio Grande do Norte, Natal, RN, Brazil.
المصدر: PloS one [PLoS One] 2022 Aug 08; Vol. 17 (8), pp. e0270749. Date of Electronic Publication: 2022 Aug 08 (Print Publication: 2022).
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science
مواضيع طبية MeSH: Tumor Necrosis Factor Inhibitors* , Tumor Necrosis Factor-alpha*/metabolism, Animals ; Mice ; Rats ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use ; Inflammation/drug therapy ; Inflammation/metabolism ; Intestines ; Peptides/pharmacology ; Peptides/therapeutic use
مستخلص: Several studies in animal models of intestinal inflammation have been performed with the aim of understanding the mechanisms of action of anti-inflammatory proteins and peptides that reduce TNF-α. In order to present the best targets, effects and strategies for the treatment of intestinal inflammation in experimental models, this systematic review (SR) aimed to answer the following question: what are the mechanisms of action of molecules with anti-TNF-α activity on the intestinal barrier? The SR protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO, number CRD42019131862) and guided by the methodological procedures used for the elaboration of the SR. Articles that were part of the SR were selected considering the eligibility criteria according to the PICO (Population, Intervention, Comparison/Control and Outcomes) and were searched in the PubMed, Scopus, Web of Science, Excerpta Medica Database (EMBASE) and ScienceDirect databases. Twenty-five articles reporting studies in rats and mice were selected and the risk of bias was assessed using the tool from the SYstematic Review Center for Laboratory Animal Experimentation (SYRCLE). A descriptive synthesis of the results obtained was carried out. Based on the results, the anti-inflammatory molecules that reduced TNF-α acted mainly on the TNF-TNFR1/TNFR2 and TLR4/MD2 complex signaling pathways, and consequently on the NF-κB pathway. This improved the aspects of the inflammatory diseases studied. In addition, these mechanisms also improved the macroscopic, histological and permeability aspects in the intestine of the animals. These findings point to the potential of protein and peptide molecules that act on inflammatory pathways for medical applications with specific and promising strategic targets, aiming to improve inflammatory diseases that affect the intestine. This systematic review also highlights the need for more details during the methodological description of preclinical studies, since this was a limitation found.
Competing Interests: the authors have declared that no competing interests exist.
References: Eur J Pharmacol. 2011 Apr 10;656(1-3):119-24. (PMID: 21296062)
Immunity. 2002 Dec;17(6):769-80. (PMID: 12479823)
Gut Microbes. 2014 Jul 1;5(4):476-84. (PMID: 25045999)
Mucosal Immunol. 2016 May;9(3):689-701. (PMID: 26376366)
Int J Mol Sci. 2019 Aug 15;20(16):. (PMID: 31443263)
Chembiochem. 2014 Oct 13;15(15):2275-80. (PMID: 25169879)
Redox Biol. 2020 Oct;37:101760. (PMID: 33096425)
Front Immunol. 2020 May 07;11:764. (PMID: 32457744)
Eur Rev Med Pharmacol Sci. 2019 Aug;23(15):6637-6644. (PMID: 31378906)
Gastroenterology. 2017 Nov;153(5):1351-1362.e4. (PMID: 28756234)
Biometrics. 1977 Mar;33(1):159-74. (PMID: 843571)
Nature. 2012 Aug 23;488(7412):508-511. (PMID: 22801493)
Burns Trauma. 2019 Dec 18;7:37. (PMID: 31890716)
Inflamm Bowel Dis. 2013 Oct;19(11):2273-81. (PMID: 23949620)
J Agric Food Chem. 2015 Dec 9;63(48):10437-47. (PMID: 26588227)
Cell Mol Life Sci. 2019 Feb;76(4):745-755. (PMID: 30413835)
Dig Dis Sci. 2020 Jul;65(7):1971-1979. (PMID: 31808003)
J Immunol. 2003 May 1;170(9):4759-66. (PMID: 12707357)
J Physiol. 2013 Aug 1;591(15):3709-23. (PMID: 23753529)
J Autoimmun. 2007 Sep-Nov;29(2-3):187-94. (PMID: 17804196)
F1000Res. 2019 Jan 28;8:. (PMID: 30755793)
Expert Rev Anti Infect Ther. 2018 Dec;16(12):939-956. (PMID: 30388900)
Immunity. 2011 May 27;34(5):637-50. (PMID: 21616434)
Int J Mol Sci. 2019 Apr 16;20(8):. (PMID: 30995806)
Fukushima J Med Sci. 2013;59(2):81-8. (PMID: 24500383)
Syst Rev. 2015 Jan 01;4:1. (PMID: 25554246)
Mucosal Immunol. 2019 Nov;12(6):1291-1303. (PMID: 31481750)
Front Immunol. 2019 Oct 04;10:2333. (PMID: 31636641)
Exp Mol Med. 2018 Aug 16;50(8):1-9. (PMID: 30115904)
Antimicrob Resist Infect Control. 2019 Nov 26;8:189. (PMID: 31788236)
Cytokine. 2018 Jan;101:56-63. (PMID: 27567553)
Nat Rev Immunol. 2016 May;16(5):321-34. (PMID: 27087664)
Medicine (Baltimore). 2019 Sep;98(39):e17285. (PMID: 31574846)
Am J Physiol Gastrointest Liver Physiol. 2007 Jul;293(1):G211-21. (PMID: 17395898)
Curr Protein Pept Sci. 2015;16(7):604-12. (PMID: 26122780)
BMC Med Res Methodol. 2014 Mar 26;14:43. (PMID: 24667063)
Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G678-83. (PMID: 17023547)
Am J Physiol Gastrointest Liver Physiol. 2009 Jun;296(6):G1167-79. (PMID: 19359427)
Immunity. 2019 Apr 16;50(4):892-906. (PMID: 30995505)
FASEB J. 2020 Dec;34(12):16049-16072. (PMID: 33058296)
Nutrients. 2017 May 15;9(5):. (PMID: 28505128)
Probiotics Antimicrob Proteins. 2021 Apr;13(2):586-597. (PMID: 33185791)
Expert Rev Clin Immunol. 2017 Mar;13(3):223-233. (PMID: 27687496)
Mol Cell Biochem. 2010 Mar;336(1-2):17-24. (PMID: 19802525)
Front Immunol. 2019 Aug 06;10:1841. (PMID: 31447849)
Front Immunol. 2020 Jun 30;11:1361. (PMID: 32695115)
المشرفين على المادة: 0 (Anti-Inflammatory Agents)
0 (Peptides)
0 (Tumor Necrosis Factor Inhibitors)
0 (Tumor Necrosis Factor-alpha)
تواريخ الأحداث: Date Created: 20220808 Date Completed: 20230814 Latest Revision: 20230814
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9359527
DOI: 10.1371/journal.pone.0270749
PMID: 35939430
قاعدة البيانات: MEDLINE
الوصف
تدمد:1932-6203
DOI:10.1371/journal.pone.0270749